Actively Recruiting
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Led by The Reading Hospital and Medical Center · Updated on 2025-07-30
65
Participants Needed
1
Research Sites
136 weeks
Total Duration
On this page
Sponsors
T
The Reading Hospital and Medical Center
Lead Sponsor
R
Reading Hospital Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study. Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study. Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled. Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
CONDITIONS
Official Title
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥ 18 years
- Diagnosis of Type 2 Diabetes with HA1c >8.0
- Current patients of the Family Healthcare Center, Reading Hospital Tower health.
You will not qualify if you...
- Identified special populations (pregnancy or individuals currently incarcerated)
- Patients without access to their own smart phone
- Any patient who is unable to provide their own informed consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Reading Hospital, an affiliate of Tower Health
West Reading, Pennsylvania, United States, 19611
Actively Recruiting
Research Team
M
Mary E Alderfer, MSN
CONTACT
P
Pamela Marrero
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here